NCT07457528
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Resectable Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Resectable Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Resectable Esophageal Squamous Cell Carcinoma trial results
NCT05043688
- Conditions
- Resectable Esophageal Squamous Cell Carcinoma
- Locations
-
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
- Anyang Tumour Hospital Anyang, China
- Sun yat-sen University Cancer Center Guangzhou, China
- Anhui Provincial Hospital Hefei, China
Not Yet Recruiting
Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer
NCT06599775
- Conditions
- Resectable Esophageal Squamous Cell Carcinoma
- Locations
-
Not specified
NCT04974047
- Conditions
- Resectable Esophageal Squamous Cell Carcinoma
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
- Union Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China